Scotia Capital’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Scotia Capital’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-352,521	Closed	-$6.91M	–	866
2024 Q3	$6.91M	Buy	+352,521	New	+$7.01M	0.04%	213
2022 Q4	–	Sell	-206,439	Closed	-$4.2M	–	787
2022 Q3	$4.2M	Buy	206,439 +163,616	+382%	+$3.26M	0.03%	234
2022 Q2	$933K	Buy	+42,823	New	+$864K	0.01%	483
2021 Q1	–	Sell	-81,709	Closed	-$1.56M	–	802
2020 Q4	$1.56M	Sell	81,709 -91,712	-53%	-$1.92M	0.01%	371
2020 Q3	$4.09M	Buy	173,421 +54,212	+45%	+$1.3M	0.04%	213
2020 Q2	$2.9M	Buy	119,209 +38,589	+48%	+$953K	0.04%	220
2020 Q1	$2.07M	Buy	+80,620	New	+$1.92M	0.03%	240

Other funds holding BTAL

TAF

Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Scotia Capital's BTAL Position: Q4 2024 in Review

Scotia Capital sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2024, closing a stake of 352,521 shares — an estimated $6.91M sold.

Scotia Capital first reported a position in BTAL in Q1 2020 and held it in 7 quarters. The position peaked at $6.91M in Q3 2024. 68 funds tracked by Wall St. Rank hold BTAL as of Q4 2024.

Scotia Capital reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2024 after selling out during the quarter.
Scotia Capital sold 352,521 AGF US Market Neutral Anti-Beta Fund shares in Q4 2024, an estimated $6.91M.
Scotia Capital first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2020 and held it in 7 quarters.
Scotia Capital's AGF US Market Neutral Anti-Beta Fund position peaked at $6.91M in Q3 2024.
68 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2024.

Based on Scotia Capital's 13F filing for Q4 2024, filed 13 Feb 2025.